带领科研团队并以课题负责人身份承担新发突发与重大传染病防控国家科技重大专项、国家十三五传染病重大专项、国家自然科学基金、首发基金及国际合作等多项科研项目，课题在研经费超1700余万元; 发表中英文章160余篇，第一／通讯作者在Nature Communications, The Lancet Regional Health - Western Pacifific，JAMA Network Open, Journal of AIDS, Journal of Infectious Diseases, Pharmacological Research上发表SCI 收录论文70余篇，累积影响因子超400分。科研团队既往在市科委重大专项和传染病重大专项的支持下，已建立了全球单个中心最大的急性期 HIV 感染者队列，且团队目前维持艾滋病抗病毒治疗长期随访队列10000余例，在艾滋病基础研究和临床诊治方面积累了丰富经验，建有艾滋病大数据样本资源库，涵盖流行病学调查信息与疾病信息。早在2006年北京市科委就已拉开了“艾滋病防治策略及综合防治研究”的序幕，由申请单位牵头，联合国家CDC、北京市CDC、北京各大医院及科研机构等十余家艾滋病研究优势单位，整合了北京地区科研及临床资源，共同完成了大型前瞻性队列研究——Beijing PRIMO Cohort（“北京原发HIV感染队列”），建立了全球最大的单中心覆盖8000人的HIV阴性MSM队列及500人的原发感染者前瞻性队列。艾滋病实验室为北京市重点实验室，实验室约占300平方米，拥有16色流式分选细胞仪、CantooII流式细胞仪、酶标仪、激光共聚焦显微镜、超速冰冻离心机、低温离心机、凝胶扫描仪、分子杂交炉、普通PCR仪、实时测序仪、ABI7900实时定量PCR仪、EasyQ病毒载量检测仪、bDNA病毒载量检测仪、倒置荧光显微镜、生物安全柜、细胞培养箱、纯水仪等实验仪器设备，可以进行免疫学、细胞生物学、分子生物学等的相关研究，这些设备基础和技术基础为本团队的科学研究提供了必要的保障。作为团队带头人组织开展多学科合作，同五官科，心血管内科，超声科均有密切合作课题及相关论文产出。

本人以课题负责人身份承担包括新发突发与重大传染病防控国家科技重大专项、首届医学高层次人才计划项目等多项国家级科研项目及国际合作项目；在研经费合计超过1700万元。在研课题如下：

1. 新发突发与重大传染病防控国家科技重大专项，课题负责人，基于AI的HIV感染代谢并发症高危人群筛选与免疫表型分析研究（2025ZD01905501），国家卫生健康委医药卫生科技发展研究中心，2025/12-2028/11，国家级，1133.50万元；

2. 新发突发与重大传染病防控国家科技重大专项，任务负责人，艾滋病并发精神神经功能障碍综合诊治新策略研究（2025ZD01905005），国家卫生健康委医药卫生科技发展研究中心，2025/12-2028/11，国家级，280万元；

3. 首届医学高层次人才计划，国家优秀青年医师，国家卫生健康委员会，2025/01-2027/12，国家级，90万元；

4. 科学推进HIV预防的创新研究计划（2022-9131），吉利德创新项目，AI聊天机器人在MSM人群HIV感染风险筛查和转介中的应用，2024/01-2026/12，国际项目，28万美元（200万元）；

5. 北京市高层次公共卫生技术人才建设项目（学科带头人-02-12），北京市卫生健康委员会，重大传染病疫情的全球卫生治理方向，2023/01-2025/12，省部级，90万元；

6. 首都卫生发展科研专项项目（重点攻关项目）（2022-1G-3011），基于HIV分子传播网络技术的艾滋病重点人群精准干预及效果评估研究，2022/01-2025/12，省部级，课题经费90万，可支配子课题经费：18万元。

近五年承担国家级、省部级及国际课题科研项目共11项，其中在研项目6项，已结题5项，在研经费超1700万元：

1. 新发突发与重大传染病防控国家科技重大专项，课题负责人，基于AI的HIV感染代谢并发症高危人群筛选与免疫表型分析研究（2025ZD01905501），国家卫生健康委医药卫生科技发展研究中心，2025/12-2028/11，国家级，1133.50万元；

2. 新发突发与重大传染病防控国家科技重大专项，任务负责人，艾滋病并发精神神经功能障碍综合诊治新策略研究（2025ZD01905005），国家卫生健康委医药卫生科技发展研究中心，2025/12-2028/11，国家级，280万元；

3. 首届医学高层次人才计划，国家优秀青年医师，国家卫生健康委员会，2025/01-2027/12，国家级，90万元；

4. 科学推进HIV预防的创新研究计划（2022-9131），吉利德创新项目，AI聊天机器人在MSM人群HIV感染风险筛查和转介中的应用，2024/01-2026/12，国际项目，28万美元（200万元）；

5. 北京市高层次公共卫生技术人才建设项目（学科带头人-02-12），北京市卫生健康委员会，重大传染病疫情的全球卫生治理方向，2023/01-2025/12，省部级，90万元；

6. 首都卫生发展科研专项项目（重点攻关项目）（2022-1G-3011），基于HIV分子传播网络技术的艾滋病重点人群精准干预及效果评估研究，2022/01-2025/12，省部级，课题经费90万，可支配子课题经费：18万元；

7. 首都卫生发展科研专项项目（2022-2-2185），北京市卫生健康委员会，血管内皮炎症因子对艾滋病合并心血管相关疾病预测作用的巢式病例对照研究，2022/01-2024/12，省部级，41.6万元（已结题）；

8. 北京市百千万人才工程项目（2020A35），北京市人才工作局，急性期治疗对HIV感染者T细胞免疫细胞特征和功能的影响；2021/01-2022/12，省部级，5.8万元（已结题）；

9. 北京市优秀人才青年拔尖个人项目（2018000021223ZK04），北京市人才工作局，HIV急性期感染者基于整合酶抑制剂抗病毒治疗方案的长期益处研究，2019/08-2022/08，省部级，50万元（已结题）；

10. 国家“十三五”艾滋病和病毒性肝炎重大传染病防治专项任务负责人，艾滋病生物标志物和疫情预警预测模型研究（2017ZX1020101101），2017/01-2020/12，国家级，可支配经费1089.83万元（已结题）；

11. 国家自然科学青年基金负责人，HIV-1感染急性期PD-1表达特征研究及作为免疫治疗靶点的初步探讨（81701984）2018/01-2020/12，国家级，20万元（已结题）。

以第一/通讯作者身份发表SCI论文情况如下：
1.    GuoY#, Lin L#, Zhang M, Yu Y, Wang Y, Cao J, Li Y, Sun X, Guan M, Wen S, Wang X,Fang Z, Duan W, Duan J, Huang T, Xia W, Guo S, Wei F*, Zheng D*, Huang X*.Salivary mycobiome alterations in HIV-infected MSM: dominance ofPseudogymnoascus and functional shifts across disease stages. Front Cell InfectMicrobiol. 2025 May 9;15:1564891. doi: 10.3389/fcimb.2025.1564891. (IF:4.6)[Q1]

2.    WangH#, Li S#, Wang R#, Wang X#, Zhang Y, Lu X, Sun J, Zhang T, Huang X*, Su B*, WuH*, Li Z*. Dynamics and immunological signature of γδ T cells followingantiretroviral therapy initiation in acute HIV-1 Infection. Front Immunol. 2025May 8;16:1554916. doi:10.3389/fimmu.2025.1554916. (IF:5.7) [Q1]

3.    WuZ#, Zhu Y#, Huang X#, Chen S, Chu Z, Wang H, Chen Y, Jiang Y, Shang H*, Hu Q*.The role of tenofovir-based HIV pre-exposure prophylaxis in preventing HBVinfection among men who have sex with men: insights from China. Infect DisPoverty. 2025 Apr 27;14(1):31. doi:10.1186/s40249-025-01305-9. (IF:4.8) [Q1]

4.    ZhaoZ#, Zheng Y#, Song X#, Peng C, Liao S, Zhang P, Tan Y, Huang X*, Zhang L*.Biological and target synthetic treatments for chronic spontaneous urticaria: Asystematic review and network meta-analysis. Clin Transl Allergy. 2025May;15(5):e70052. doi:10.1002/clt2.70052. (IF:4.6) [Q2]

5.    ZhaoZ#*, Peng C#, Liu L#, Zheng Y, Tan Y, Song X, Zhang P, Huang X*, Zhang L*.Upadacitinib and Dupilumab Demonstrate Superior Efficacy in the Treatment ofAdolescent Atopic Dermatitis: A Network Meta-Analysis. Int Arch AllergyImmunol. 2025 Jan 17:1-11. doi:10.1159/000543397. (IF:2.5) [Q3]

6.    ZhaoS, Wang W, Li S, He J, Duan W, Fang Z, Ma X, Li Z, Guo C, Wang W, Wu H*, ZhangT*, Huang X*. The prevalence of low-level viraemia and its association withvirological failure in people living with HIV: a systematic review andmeta-analysis. Emerg Microbes Infect. 2024 Dec;14(1):2447613.doi:10.1080/22221751.2024.2447613. (IF:8.4) [Q1]

7.    YeJ#, Dong Y#, Lan Y#, Chen J#, Zhou Y#, Liu J#, Yuan D#, Lu X#, Guo W#, ZhengM#, Yang H#, Song X#, Liu C#, Zhou Q#, Zheng C#, Guo Q#, Yang X#, Zhang L#, GeZ#, Liu L#, Yu F#, Han Y#, Huang H#, Hao M#, Ruan Y#, Wu J#, Li J#, Chen Q#,Ning Z#, Ling X#, Zhou Y#, Liu X#, Bai J#, Gao Y#, Tong X#, Mei F#, Yang Z#,Wang A#, Wei W#, Qiao R#, Luo X#, Huang X#, Wang J#, Shen X#, Hu F#, Zhang L#,Tan W#, Fan J#, Tu A#, Yu G#, Fang Y#, He S#, Chen X#, Wu D#, Zhang X#, Xin R#,He X#, Ren X#, Xu C#, Sun Y, Li Y#, Liu G#, Li X#, Duan J#, Huang T#, Shao Y#,Feng Y#, Pan Q#, Su B#, Jiang T#, Zhao H#, Zhang T#, Chen F#, Hu B#, Wang H#,Zhao J#, Cai K#, Sun W#, Gao B#, Ning T#, Liang S#, Huo Y#, Fu G#, Li F#, LinY*, Xing H*, Lu H*. Trends and Patterns of HIV Transmitted Drug Resistance inChina From 2018 to 2023. J Infect Dis. 2024 Dec 16;230(6):1410-1421. doi:10.1093/infdis/jiae303. (IF:5.0) [Q1]

8.    YeJ, Lan Y#, Wang J#, Feng Y#, Lin Y#, Zhou Y#, Liu J#, Yuan D#, Lu X#, Guo W#,Zheng M#, Song X#, Zhou Q#, Yang H#, Zheng C#, Guo Q#, Yang X#, Yang K#, ZhangL#, Ge Z#, Liu L#, Yu F#, Han Y#, Huang H#, Hao M#, Chen Q#, Ling X#, Ruan Y#,Dong Y#, Zhou C#, Liu X#, Bai J#, Tong X#, Gao Y#, Yang Z#, Wang A#, Wei W#,Mei F#, Qiao R#, Luo X#, Huang X#, Chen J#, Hu F#, Shen X#, Tan W#, Tu A#,Zhang X#, He S#, Ning Z#, Fan J#, Liu C#, Xu C#, Ren X#, Sun Y#, Li Y#, Liu G#,Li X#, Li J#, Duan J#, Huang T#, Liu S#, Yu G#, Wu D#, Shao Y#, Pan Q#, ZhangL#, Su B#, Wu J#, Jiang T#, Zhao H#, Zhang T#, Chen F, Cai K#, Hu B#, Wang H#,Zhao J#, Gao B#, Sun W#, Ning T#, Li J#, Liang S#, Huo Y#, Fu G#, Chen X#, LiF*, Xing H*, Lu H*. Improvement in the 95-95-95 Targets Is Accompanied by aReduction in Both the Human Immunodeficiency Virus Transmission Rate andIncidence in China. J Infect Dis. 2024 Aug 26:jiae302. doi:10.1093/infdis/jiae302. (IF:5.0) [Q1]

9.    LiuH#, Wang W#, Zhang Y, Wang F, Duan J, Huang T, Huang X*, Zhang T*. GlobalPerspectives on Smallpox Vaccine against Monkeypox: A ComprehensiveMeta-Analysis and Systematic Review of Effectiveness, Protection, Safety andCross-immunogenicity. Emerg Microbes Infect. 2024 Jul 31:2387442. doi:10.1080/22221751.2024.2387442. (IF:8.4) [Q1]

10.  GuoY#, Wang W#, Yu Y, Sun X, Zhang B, Wang Y, Cao J, Wen S, Wang X, Li Y, Cai S,Wu R, Duan W, Xia W, Wei F, Duan J, Dong H, Guo S, Zhang F*, Sun Z*, Huang X*.Crosstalk between human immunodeficiency virus infection and salivary bacterialfunction in men who have sex with men. Front Cell Infect Microbiol. 2024 May8;14:1341545. doi: 10.3389/fcimb.2024.1341545. (IF:5.7) [Q1]

11.  ZhuS#, Wang W#, He J#, Duan W, Ma X, Guan H, Wu Y, Li S, Li Y, Tian T, Kong W, WuD, Zhang T, Huang X*. Higher cardiovascular disease risks in people living withHIV: A systematic review and meta-analysis. J Glob Health. 2024 Apr26;14:04078. doi: 10.7189/jogh.14.04078. (IF:7.2) [Q1]

12.  TingtingMei#, Xiaojie Huang#, Shan Tang, Menglu Liu, Wenyan Zhang, Haibin Yu*. Effectsof sustained viral response on lipid in hepatitis C: a systematic review andmeta-analysis. Lipids in Health and Disease. Lipids Health Dis. 2024 Mar9;23(1):74. doi: 10.1186/s12944-023-01957-2. (IF:4.5) [Q2]

13.  JiaL#, Yan B#, Fang Y, Yang X, Jia H, Zhang M, Li S, Zhang Y, Wang W, Guo C, ZhangT, Huang X*, Jiang T*. Cases of Monkeypox show highly-overlapping co-infectionwith HIV and syphilis. Front Public Health. 2024 Jan 5;11:1276821. doi:10.3389/fpubh.2023.1276821. (IF:5.2) [Q1]

14.  XinshengWu#, Guohui Wu#, Ping Ma#, Rugang Wang#, Linghua Li#, Yuanyi Chen, Junjie Xu,Yuwei Li, Quanmin Li, Yuecheng Yang, Lijing Wang, Xiaoli Xin, Ying Qiao,Gengfeng Fu*, Xiaojie Huang*, Bin Su*, Tong Zhang*, Hui Wang*, Huachun Zou*.Associations of modern initial antiretroviral therapy regimens with all-causemortality in people living with HIV in resource-limited settings: aretrospective multicenter cohort study in China. Nature Communications. 2023Sep 2;14(1):5334. doi: 10.1038/s41467-023-41051-w. (IF:16.6) [Q1]

15.  XinshengWu#, Guohui Wu#, Ping Ma#, Rugang Wang#, Linghua Li#, Yinghui Sun, Junjie Xu,Yuwei Li, Tong Zhang, Quanmin Li, Yuecheng Yang, Lijing Wang, Xiaoli Xin, YingQiao, Bingxue Fang, Zhen Lu, Xinyi Zhou, Yuanyi Chen, Qi Liu, Gengfeng Fu,Hongxia Wei*, Xiaojie Huang*, Bin Su*, Hui Wang*, Huachun Zou*. Immediate andlong-term outcomes after treat-all among people living with HIV in China: aninterrupted time series analysis. Infectious diseases of poverty. 2023 Aug14;12(1):73. doi: 10.1186/s40249-023-01119-7. (IF:8.1) [Q1]

16.  WenjingWang #, Shengnan Zhao #, Yaxin Wu #, Wenshan Duan, Sibo Li, Zhen Li, CaipingGuo, Wen Wang, Tong Zhang, Hao Wu, Xiaojie Huang*. Safety and Efficacy ofLong-Acting Injectable Agents for HIV-1: Systematic Review and Meta-Analysis.JMIR Public Health Surveill. 2023 Jul 27;9:e46767. doi: 10.2196/46767. (IF:8.5)[Q1]

17.  MengluLiu#, Hanying Qiu#, Wenyan Zhang, Tingting Mei, Shan Tang, Yuxue Gao, YanqiuZhu, Xiaojie Huang*, Haibin Yu*. Evaluation of blood-based PRO-C3 testing as adiagnostic marker for staging liver fibrosis: A systematic review andmeta-analysis. J Gastroenterol Hepatol. 2023 Jul;38(7):1018-1027. doi:10.1111/jgh.16240. (IF:4.369) [Q2]

18.  ZhenLi#*, Ping Yan#, Rui Wang, Xiaofan Lu, Yang Zhang, Bin Su, Xin Zhang, Lin Yuan,Zhiying Liu, Wei Jiang, Tong Zhang, Hao Wu*, Xiaojie Huang*. Persistent T cellproliferation and MDSCs expansion precede incomplete CD4+ T cell recovery inpeople with acute HIV-1 infection with early ART. Heliyon. 2023 Apr18;9(5):e15590. doi: 10.1016/j.heliyon.2023.e15590. (IF:3.776) [Q1]

19.  YangZhao#, Juan Du#, Zhen Li, Yaxin Wu, Wenshan Duan, Wenjing Wang, Tong Zhang,Junjie Xu*, Hao Wu*, Xiaojie Huang*. It Is Time to Improve the Acceptance ofCOVID-19 Vaccines Among People with Chronic Diseases: A Systematic Review andMeta-analysis. J Med Virol. 2023 Feb;95(2):e28509. doi: 10.1002/jmv.28509. (IF:20.693) [Q1]

20.  ChiZhou#, Yaxin Wu#, Yang Zhang#, Yingying Wang, Hao Wu, Tong Zhang*, GuanzhiChen*, Xiaojie Huang*. Factors Associated with Post-treatment Control of ViralLoad in HIV-Infected Patients: A Systematic Review and Meta-analysis. Int JInfect Dis. 2023 Apr;129:216-227. doi: 10.1016/j.ijid.2023.01.025. (IF: 12.074)[Q1]

21.  JiaojiaoLiu#, Benedictor Alexander Nguchu#, Dan Liu, Yu Qi, Xire Aili, Shuai Han, YuxunGao, Xiaoxiao Wang, Hongwei Qiao, Chao Cai, Xiaojie Huang*, Hongjun Li*.Longitudinal white matter alterations in SIVmac239-infected rhesus monkeys withand without regular cART treatment. Front Immunol. 2023 Jan 12;13:1067795. doi:10.3389/fimmu.2022.1067795. (IF: 8.786) [Q1]

22.  XiangfeiXiu, Yuanyuan Qin, Yugang Bao, Yaokai Chen, Hao Wu, Xiaojie Huang*, Lu Wang*.The Practice and Potential Role of HIV Self-testing in China: Systematic Reviewand Meta-analysis. JMIR Public Health Surveill. 2022 Dec 2;8(12):e41125. doi:10.2196/41125. (IF: 14.557) [Q1]

23.  SisiChen#, Feng Ren#, Ling Xu, Yao Gao, Xiangying Zhang, Yaling Cao, Zihao Fan,Yuan Tian, Xiaojie Huang*, Mei Liu*. Underestimated Prevalence of HIV,Hepatitis B Virus (HBV), and Hepatitis D Virus (HDV) Triple Infection Globally:Systematic Review and Meta-analysis. JMIR Public Health Surveill. 2022 Nov29;8(11):e37016. doi: 10.2196/37016. (IF:14.557) [Q1]

24. Xinsheng Wu#, Guohui Wu#, Yanmin Ma#, Xiaojie Huang#, Yuecheng Yang#, Yanshan Cai#, Ganfeng Luo, Ping Ma, Ying Qiao, YuanyiChen, Yi-Fan Lin, Yanxiao Gao, Yuewei Zhan, Wei Song, Yingying Wang, RugangWang, Xuejuan Yang, Lijun Sun, Hongxia Wei, Quanmin Li, Xiaoli Xin, LijingWang, Xicheng Wang, Ronghui Xie, Lijuan Yang, Xiaojun Meng, Jin Zhao*, LinghuaLi*, Tong Zhang*, Junjie Xu*, Gengfeng Fu*, Huachun Zou*. The impact ofCOVID-19 non-pharmaceutical interventions on HIV care continuum in China: an interruptedtime series analysis. The Lancet Regional Health-Western Pacific. 2022 Aug10;29:100569. doi: 10.1016/j.lanwpc.2022.100569.（IF：8.559）[Q1]

25.  Yaxin Wu#, Yuening Zhang#, Yingying Wang, Jiaqi Wei, Wenjing Wang, Wenshan Duan,Yakun Tian, Meixin Ren, Zhen Li, Wen Wang, Tong Zhang, Hao Wu, Xiaojie Huang*.Bedaquiline and Linezolid improve anti-TB treatment outcome in drug-resistantTB patients with HIV: A systematic review and meta-analysis. Pharmacol Res.2022 Aug;182:106336. doi: 10.1016/j.phrs.2022.106336. (IF:10.334) [Q1]

26.  Kui-FangDu#, Xiao-Jie Huang#, Chao Chen, Wen-Jun Kong, Lian-Yong Xie, Hong-Wei Dong*and Wen-Bin Wei *. Macular Changes Observed on Optical Coherence TomographyAngiography in Patients Infected with Human Immunodeficiency Virus WithoutInfectious Retinopathy. Front Med (Lausanne). 2022 Apr 7; 9:820370. doi:10.3389/fmed.2022.820370. (IF:5.058) [Q1]

27. YanYu, Xinyu Wang, Yaxin Wu, Wenjia Weng, Ming Zhang, Juan Li, Xiaojie Huang*,Yanqing Gao*. The benefits of psychosocial interventions for mental health inmen who have sex with men living with HIV: a systematic review andmeta-analysis. BMC Psychiatry. 2022 Jun 29;22(1):440. doi:10.1186/s12888-022-04072-1. (IF:4.144) [Q2]

28. HongyiWang#, Zixin Wang#, Xiaojie Huang#, Yaokai Chen, Hui Wang, Sitong Cui, JingZhang, Zhenxing Chu, Qinghai Hu, Haibo Ding, Hanzhu Qian, Huachun Zou, WeimingTang, Yangyang Gao, Xia Jin, Zhaozhen Liu, Lukun Zhang, Jin Zhao, Xiaoqing He,Yongjun Jiang, Wenqing Geng, Junjie Xu*, Hong Shang*; for the China Real-WorldOral Intake of PrEP (CROPrEP) Study Team. Association of HIV preexposureprophylaxis use with HIV incidence among men who have sex with men in China: anonrandomized controlled trial. JAMA Network Open. 2022 Feb 1;5(2):e2148782.doi: 10.1001/jamanetworkopen.2021.48782. (IF:13.353) [Q1]

29. KeZhang#, Yang Zhang#, Jing Zhou, Lulu Xu, Chi Zhou, Guanzhi Chen*, Xiaojie Huang*. Comparison of the Efficacy and Safety of a Doravirine-Based, Three-DrugRegimen in Treatment-Naïve HIV-1 Positive Adults: A Bayesian NetworkMeta-Analysis. Front Pharmacol. 2022 Apr 20;13: 676831. doi:10.3389/fphar.2022.676831. (IF:5.988) [Q1]

30.  XiaoyanBi#, Fan Liu#, Xiangjun Zhang, Hongyi Wang, Zehao Ye, Ke Yun, Xiaojie Huang#,Haibo Ding, Wenqing Geng, and Junjie Xu*. Vitamin D and calcium supplementationreverses Tenofovir-caused bone mineral density loss in populations attendingART or PrEP: a systematic review and meta-analysis. Front Nutr. 2022 Mar 31;9:749948. doi: 10.3389/fnut.2022.749948. (IF:6.59) [Q1]

31.  Xiaojie Huang #, Ying Yan #, Bin Su #, Dong Xiao#, Maohe Yu, Xia Jin, Junyi Duan,Xiangjun Zhang, Shimin Zheng, Yuan Fang, Tong Zhang, Weiming Tang *, Lunan Wang*, Zixin Wang * and Junjie Xu*. Comparing Immune Responses to InactivatedVaccines against SARS-CoV-2 between People Living with HIV and HIV-NegativeIndividuals: A Cross-Sectional Study in China. Viruses. 2022 Jan 28;14(2):277.doi: 10.3390/v14020277. (IF:5.818) [Q2]

32.  XinyuWang#, Ming Zhang#, Yu Chen, Yirong Liu, Yan Yu, Xiaojie Huang*. Yanqing Gao*.Risk for Hepatitis B Virus Reactivation in Patients with Psoriasis Treated withBiological Agents: A Systematic Review and Meta-Analysis. Dermatol Ther(Heidelb). 2022 Mar;12(3):655-670. doi: 10.1007/s13555-022-00682-5. (IF:3.858)[Q1]

33.  YakunTian#, Wei Hua#, Yaxin Wu#, Tong Zhang, Wen Wang, Hao, Wu, Caiping Guo*,Xiaojie Huang*. Immune response to hepatitis B virus vaccine among peopleliving with HIV: a meta-analysis. Front Immunol, 2021 Dec 22;12: 745541. doi:10.3389/fimmu.2021.745541 (IF:8.786) [Q1]

34.  XiaojingLian#, Lili Zhang#, Yang Zhao#, Yuhua Li, Xuemin Jing, Xin Liu, Jianing Han,Jianhong Ma, Yongyong Zhang, Huimin Guo*, Xiaojie Huang*. Utilization of amobile multifunctional workstation for coronavirus nasopharyngeal/oropharyngealspecimen collection. Front Public Health, 2021 Jan 24;9:794359. doi:10.3389/fpubh.2021.794359. eCollection 2021. (IF:6.461) [Q1]

35.  YingGuo#, Xiaojie Huang#, Xintong Sun, Yixi Yu, Yan Wang, Baojin Zhang, Jie Cao,Shuo Wen, Yuchen Li, Xin Wang, Siyu Cai, Wei Xia, Feili Wei, Junyi Duan, HaozhiDong, Shan Guo, Fengqiu Zhang*, Dongxiang Zheng* and Zheng Sun*. The underratedsalivary virome of men who have sex with men infected with HIV. Front Immunol,2021 Dec 2;12: 759253. doi: 10.3389/fimmu.2021.759253 (IF:8.786) [Q1]

36.  ZhuangTao, Xiao-Jie Huang#, Ying Liu, Ru Wang, Ji-Peng Dong, Bi-Yan Liang, Wen Zou,Guo-Jian Gao, Zhuo Wang, Ke Zhang, Hao Wu, Tong Zhang, Jian Wang*. Efficacy ofintegrated Traditional Chinese Medicine and anti-retroviral therapy onimmunological nonresponse in patients with human immunodeficiencyvirus/acquired immunodeficiency syndrome: a Meta-analysis of randomizedcontrolled trial. J Tradit Chin Med. 2021 Oct;41(5):669-676. doi:10.19852/j.cnki.jtcm.2021.05.002. (IF: 2.547) [Q2]

37.  HuanXia#, Xiao-Jie Huang#, Yue Hu, Li-Ying Gao, Yue Wu, Hao Wu, Zhong-Fang Yan,Ping Ma*. Switching from efavirenz toelvitegravir/cobicistat/emtricitabine/tenofovir alafenamide reduces centralnervous system symptoms in people living with human immunodeficiency virus.Chin Med J (Engl). 2021 Oct 13. doi:10.1097/CM9.0000000000001824. (IF:6.133)[Q1]

38.  ChunxiangGuo#, Yaxin Wu#, Yang Zhang, Xinchao Liu, Aixin LI, Meixia Gao, Tong Zhang, HaoWu, Guanzhi Chen*, Xiaojie Huang *. Transmitted drug resistance in ART-naivepersons with acute/ early/ primary HIV infection: a systematic review andmeta-analysis. Frontiers in Pharmacology. 2021 Nov 24;12: 718763. doi:10.3389/fphar.2021.718763 (IF:5.988) [Q1]

39.  Xiaojie Huang#, Maohe Yu#, Gengfeng Fu#, Guanghua Lan#, Linghua Li#, Jianzhou# Yang,Ying Qiao#, Jin Zhao#, Han-Zhu Qian, Xiangjun Zhang, Xinchao Liu, XiaJin,Guohong Chen, Hui Jiang, Weiming Tang*, Zixin Wang*, Junjie Xu*.Willingness to receive COVID-19 vaccination among people living with HIV andAIDS in China: A nationwide cross-sectional online survey. JMIR Public HealthSurveill. 2021 Oct 21;7(10): e31125. doi: 10.2196/31125. (IF:14.557) [Q1]

40.  NiWang, Muyu Wang, Xin Xin, Tong Zhang, Hao Wu, Xiaojie Huang* and Honglei Liu*.Exploring the Relationship between Anxiety, Depression, and Sleep Disturbanceamong HIV Patients in China from a Network Perspective. Front Psychiatry. 2021Oct 22;12: 764246.doi: 10.3389/fpsyt.2021.764246. (IF:5.435) [Q2]

41.  YingyingWang#, Xiaojie Huang#, Yaxin Wu, Aixin Li, Yakun Tian, Meixin Ren, Zhen Li,TongZhang, Hao Wu and Wen Wang*. Increased Risk of Vitamin D Defificiency AmongHIV-Infected Individuals: A Systematic Review and Meta-Analysis. Front Nutr.2021 Aug 18;8: 722032. doi: 10.3389/fnut.2021.722032. (IF:6.59) [Q1]

42. KeZhang, Yang Zhang, Xincao Liu, Ainxin Li, Meixia Gao, Jianhua Hou, ChunxiangGuo, Tong Zhang, Hao Wu, Xiaojie Huang*, Guanzhi Chen*. Three-drug regimenscontaining integrase inhibitor show good efficacy and safety in treatment-naivepatients with HIV-1: a Bayesian analysis. Front Pharmacol. 2021 Jul 21;12:603068. doi: 10.3389/fphar.2021.603068. (IF:5.988) [Q1]

43.  JingZhang#, Xiao-jie Huang#, Wei-ming Tang#, Zhen-xing Chu#, Qing-hai Hu, Jing Liu,Haibo Ding, Xiao-xu Han, Zi-ning Zhang, Yong-jun Jiang, Wen-qing Geng, Wei Xia, Jun-jie Xu* and Hong Shang*. Rapid Clinical Progression and Its CorrelatesMen in China with Acute HIV Who Have Sex With Men: Findings From a 5-YearMulticenter Prospective Cohort Study. Front Immunol. 2021 Jul 22;12: 712802.doi: 10.3389/fimmu.2021.712802. (IF:8.786) [Q1]

44.  YangZhao, Xiaoli Xin, Huiwen Deng, Junjie Xu, Wenjia Weng, Ming Zhang, Juan Li,Yanqing Gao, Xiaojie Huang*, Cuie Liu*. Improving the acceptability of humanpapillomavirus vaccines among men who have sex with men according to thecorrelated factors: a systematic review and meta-analysis. Front Pharmacol.2021 Mar 24;12: 600273. doi: 10.3389/fphar.2021.600273. (IF: 5.81) [Q1]

45.  Guo,Y#, Xia, W, Wei, F, Feng, W, Duan, J, Sun, X, Yu, Y, Wang, Y, Zhang, B, Cao, J,Li, W, Dong, H, Guo, S, Zhang, F*, Huang, X* & Sun, Z*. Salivary microbialdiversity at different stages of human immunodeficiency virus infection. MicrobPathog. 2021 Jun;155: 104913. doi: 10.1016/j.micpath.2021.104913. (IF:3.847)[Q3]

46.  HuX#, Huang X#, Hou J, Ding L, Su C, Meng F*. Diagnostic accuracy of spleenstiffness to evaluate portal hypertension and esophageal varices in chronicliver disease: a systematic review and meta-analysis. Eur Radiol. 2021Apr;31(4):2392-2404. doi: 10.1007/s00330-020-07223-8. (IF=4.101) [Q1]

47.  Xia,H. #, Gao, L. #, Gong, X., Zaongo, S. D., Zhang, T., Wu, H., Ma, P. * &Huang, X*. The Challenge of Potential Drug–Drug Interactions Among PeopleLiving With HIV on Antiretroviral Therapy: A Cross-Sectional Study in SelectedProvinces in China. Frontiers in Pharmacology. 2020, May 27;11:800. doi:10.3389/fphar.2020.00800. eCollection 2020. (IF:4.225) [Q1]

48.  Li,Y. #, Huang, X. #, Chen, H., Qin, Y., Hou, J., Li, A., Wu,H. , Yang, X.&Chen, Y*. The prevalence of cryptococcal antigen (CrAg) and benefits ofpre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cellcounts< 200 cells/μL: evidence based on a meta-analysis. BMC InfectiousDiseases. 2020 Jun 12;20(1):410. doi: 10.1186/s12879-020-05126-z. (IF:2.688)[Q3]

49.  Qin,Y. #, Huang, X. #, Chen, H., Liu, X.Li, Y., Hou, J., Li, A., Yan, X, Chen, Y*.Burden of Talaromyces marneffei infection in people living with HIV/AIDS inAsia during ART era:a systematic review and meta-analysis. BMC InfectiousDiseases. 2020 Jul 29;20(1):551. doi: 10.1186/s12879-020-05260-8. (IF:2.688)[Q3]

50.  YuanGao #, Qi Li #, Hongbo Shi #, Yingmei Feng, Tong Zhang, Yu Chen, LianchunLiang, Dexi Chen, Hao Wu, Ronghua Jin, Xiaojie Huang *. Preliminary Explorationof the Cause of Liver Disorders During Early Stages in COVID-19 Patients.Frontiers in Medicine. 2020 Aug 7;7:501. doi: 10.3389/fmed.2020.00501. (IF:3.9)[Q2]

51.  XuJJ#, Huang XJ#, Liu XC, Wang LM, Chen YK, Wang H, Zhang FJ, Wu H, Li TS, HanMJ, Zhao F, Ding HB, Duan JY, Sheng GS, Shang H*. Consensus statement on humanimmunodeficiency virus pre-exposure prophylaxis in China. Chin Med J (Engl).2020 Dec 5;133(23):2840-2846. doi: 10.1097/CM9.0000000000001181. (IF=1.555)[Q1]

52.  Huang X#, Xu L#, Sun L, Gao G, Cai W, Liu Y, Ding H, Wei H, Ma P, Wang M, Liu S, ChenY, Chen X, Zhao Q, Yu J, Song Y, Chen H, Wu H, Qin S*, Li L*. Six-yearImmunologic Recovery and Virological Suppression of LPV/r-based Second-lineAntiretroviral among HIV Patients: A Multi-center Real-world Cohort Study inChina. Frontiers in Pharmacology. 2019 Dec 11;10:1455. doi:10.3389/fphar.2019.01455. (IF:3.845) [Q1]

53.  HuangY#, Huang X#, Chen H, Wu H*, Chen Y*. Efficacy and safety of raltegravir baseddual therapy in AIDS patients: a meta-analysis from randomized controlledtrials. Frontiers in Pharmacology. 2019 Oct 17;10:1225. doi:10.3389/fphar.2019.01225. (IF:3.845) [Q1]

54.  ZhangY, Hou J, Shi P, Chang S, Wu A, Song A, Wu H, Huang X*, Shi J*. Problem-basedlearning could tackle the issue of insufficient education and adherence inpeople living with HIV/AIDS[J]. Frontiers in pharmacology. 2019 Aug 21;10:901.doi: 10.3389/fphar.2019.00901. (IF:3.845) [Q1]

55.  ZhiyuanYang#, Xiaojie Huang#, Xinchao Liu, Jianhua Hou, Wenfang Wu,Aixin Song,Kathrine Meyers, Tong Zhang, Hui Chen*, Hao Wu*. Psychometric Properties andFactor Structure of the Chinese Version of the Hospital Anxiety and DepressionScale in People Living With HIV. Frontiers in Psychiatry. 2019 May 16;10:346.doi: 10.3389/fpsyt.2019.00346. (IF:2.875) [Q2]

56.  HuX#, Huang X#, Chen H, Zhang T, Hou J, Song A, Ding L, Liu W, Wu H*, Meng F*.Diagnostic effect of shear wave elastography imaging for differentiation ofmalignant liver lesions: a meta-analysis. BMC gastroenterology. 2019 Apr25;19(1):60. doi: 10.1186/s12876-019-0976-2. (IF:2.252) [Q4]

57.  Xiaojie Huang #, Xinchao Liu #, Jieqing Chen #, Yugang Bao, Hou Jianhua, Lu Xiaofan,Xia Wei, Xia Huan, Song Aixin, Liu Zhiying, Su Bin, Chen Hui*, Chen Yaokai*, WuHao*. Evaluation of Blood-Based Antibody Rapid Testing for HIV Early Therapy: AMeta-Analysis of the Evidence. Frontiers in Immunology. 2018 Jun 26;9:1458.doi: 10.3389/fimmu.2018.01458.（IF:5.511）[Q1]

58.  YinqiuHuang#, Xiaojie Huang#, Yadong Luo, Yihong Zhou, Xingbao Tao, Hui Chen, AixinSong, Yaokai Chen *, Hao Wu *. Assessing the Efficacy ofLopinavir/Ritonavir-Based Preferred and Alternative Second-Line Regimens inHIV-Infected Patients: A Meta-Analysis of Key Evidence to Support WHORecommendations. Frontiers in pharmacology. 2018 Aug 14;9:890. doi:10.3389/fphar.2018.00890. (IF:3.831) [Q1]

59.  Xiaojie Huang#, Jianhua Hou#, Aixin Song, Xinchao Liu, Xiaodong Yang, Junjie Xu, JingZhang, Qinghai Hu, Hui Chen, Yaokai Chen, Kathrine Meyers *, Hao Wu *. Efficacyand safety of oral TDF-based pre-exposure prophylaxis for men who have sex withmen: A systematic review and meta-analysis. Frontiers in pharmacology. 2018 Sep4;9:799. doi: 10.3389/fphar.2018.00799.（IF:3.831）[Q1]

60.  Xiaojie Huang #, Kathrine Meyers #, Xinchao Liu #, Xia Li, Tong Zhang, Wei Xia, JiahuaHou, Aixin Song, Haolan He, Chongxi Li, Shenghua He, Weiping Cai, Huolin Zhong,Chengyu Huang, Shuiqing Liu, Hui Wang, Xuemei Ling, Ping Ma, Rongxia Ye, GangXiao, Taisheng Li, Ding Ding, Kristine Yaffe, Hui Chen *, Yaokai Chen *, Hao Wu*. The Double Burdens of Mental Health Among AIDS Patients with FullySuccessful Immune Restoration: A Cross-Sectional Study of Anxiety andDepression in China. Frontiers in Psychiatry. 2018 Aug 24;9:384. doi:10.3389/fpsyt.2018.00384. (IF: 2.875) [Q2]

61.  AixinSong #, Xinchao Liu #, Xiaojie Huang #, Kathrine Meyers, Djin Ye Oh, JianhuaHou, Wei Xia, Bin Su, Ni Wang, Xiaofan Lu, Huan Xia, Xiaodong Yang, Hui Chen *,Hao Wu *. From CD4-Based Initiation to Treating All HIV-Infected AdultsImmediately: An Evidence-Based Meta-analysis. Frontiers in Immunology. 2018 Feb13;9:212. doi: 10.3389/fimmu.2018.00212. (IF: 6.429) [Q1]

62.  Xiaojie Huang#, Huiqin Li#, Kathrine Meyers #, Wei Xia, Zhihao Meng, Chongxi Li,Jinsong Bai, Shenghua He, Weiping Cai, Chengyu Huang, Shuiqing Liu, Hui WangXuemei Ling, Ping Ma, Daling Tan, Fuxiang Wang, Lianguo Ruan, Hongxin Zhao,HongxiaWei, Yanfen Liu, Jianhua Yu, Hongzhou Lu, Min Wang, Tong Zhang, HuiChen*, Hao Wu*. Burden of sleep disturbances and associated risk factors: Acrosssectional survey among HIV infected persons on antiretroviral therapyacross China. Scientific Reports. 2017 Jun 16;7(1):3657. doi:10.1038/s41598-017-03968-3. (IF: 4.259) [Q2]

63.  Xiaojie Huang#, Xinchao Liu #, Kathrine Meyers #, Lihong Liu, Bin Su, Pengfei Wang,Zhen Li, Lan Li, Tong Zhang, Ning Li, Hui Chen*, Haiying Li*, Hao Wu*. Cytokinecascade and networks among MSM HIV seroconverters: implications for earlyimmunotherapy. Scientific Reports. 2016 Nov 10;6:36234. doi: 10.1038/srep36234.(IF: 5.228) [Q2]

64.  XiaofanLu #, Bin Su #, Huan Xia, Xin Zhang, Zhiying Liu, Yunxia Ji, Zixuan Yang, LiliDai, Luzia M. Mayr, Christiane Moog, Hao Wu, Xiaojie Huang* and Tong Zhang*.Low Double-Negative CD3+CD4−CD8− T Cells Are Associated with IncompleteRestoration of CD4+ T Cells and Higher Immune Activation in HIV-1 ImmunologicalNon-Responders. Front Immunol. 2016 Dec 9;7:579. doi: 10.3389/fimmu.2016.00579.(IF: 5.695) [Q1]

65.  Xiaojie Huang #, Yuanlong Xu#, Qiuying Yang, Jieqing Chen, Tong Zhang, ZaiCun Li,Caiping Guo, Hui Chen*, Hao Wu*, Ning Li*. Efficacy and biological safety oflopinavir/ritonavir based anti-retroviral therapy in HIV-1-infected patients: ameta-analysis of randomized controlled trials. Scientific Reports. 2015 Feb23;5:8528. doi: 10.1038/srep08528. (IF: 5.578) [Q2]

66.  ZhongweiJia #, Xiaojie Huang #, Hao Wu* #, Tong Zhang #, Ning Li, Peipei Ding,YixuanSun, Zhiying Liu, Feili Wei, Hongwei Zhang, Yanmei Jiao, Yunxia Ji, YonghongZhang, Caiping Guo, Wei Li, Danlei Mou, Wei Xia, Zhen Li, Dexi Chen, HuipingYan, Xinyue Chen, Jinkou Zhao, Kathrine Meyers, Ted Cohen, Kenneth Mayer,Joshua A Salomon, Zuhong Lu *, Christopher Dye*. HIV burden in men who have sexwith men: a prospective cohort study 2007–2012. Scientific Reports. 2015 Jul2;5:11205. doi: 10.1038/srep11205. (IF: 5.578) [Q2]

67.  Xiaojie Huang, Sara Lodi , Zoe Fox,Wei Li, Andrew Phillips, Kholoud Porter, IrjaLutsar, Anthony Kelleher, Ning Li, Xiaoning Xu , Hao Wu* and Anne M Johnson. Beijing PRIMO cohort study,CASCADE Collaboration in EuroCoord. Rate of CD4 decline and HIV-RNA changefollowing HIV Seroconversion in men who have sex with men: a comparison betweenthe Beijing PRIMO and CASCADE cohorts. JAIDS. 2013 Apr 1;62(4):441-6. doi:10.1097/QAI.0b013e31827f5c9a. (IF: 4.653) [Q3]

68.  ChenJ#, Li W#, Huang X#, Guo C#, Zou R, Yang Q, Zhang H, Zhang T, Chen H*, Wu H*.Evaluating Total Lymphocyte Count as a Surrogate Marker for CD4 Cell Count inthe Management of HIV-Infected Patients in Resource-Limited Settings: A Studyfrom China. PLoS ONE. 2013 Jul 18;8(7):e69704. doi:10.1371/journal.pone.0069704. (IF:3.73) [Q2]

69.  Xiaojie Huang, Hui Chen, Wei Li, Haiying Li, Xia Jin, Alan S. Perelson, Zoe Fox, TongZhang, Xiaoning Xu, Hao Wu*. Precise determination of time to reach viral loadset point after acute HIV-1 infection. JAIDS. 2012 Dec 1;61(4):448-54. doi:10.1097/QAI.0b013e31827146e0. (IF:4.653) [Q3]

70. ChaoWang#, YouXin Wang#, XiaoJie Huang#, Xia Li , YouXin Wang , Tong Zhang , ManShuSong *, LiJuan Wu , Juan Du , XiaoQin Lu , Shuang Shao , FeiFei Zhao , MicheleA. Ball, Hao Wu*, Wei Wang*. Prevalence and Factors Associated with Hepatitis BImmunization and Infection among Men Who Have Sex with Men in Beijing, China.Plosone. 2012;7(10):e48219. doi: 10.1371/journal.pone.0048219. (IF:4.092) [Q2]

71.  WeiLi#, Xiaojie Huang#, Hongfei Tong, Yuxuan Wang, Tong Zhang, Wen Wang, LiliDai,Tongzeng Li, Shengzhang Lin* ,Hao Wu*. Comparison of the regulation ofβ-catenin signaling by type I, type II and type III interferons inhepatocellular carcinoma cells. Plos One. 2012;7(10):e47040. doi:10.1371/journal.pone.0047040. (IF: 4.092) [Q2]

72.  WeiLi#, Xiaojie Huang#, Zhuoming Liu, Yuxuan Wang, Hongwei Zhang, Hongfei Tong,Hao Wu*, Shengzhang Lin*. Type III interferon induces apoptosis in human lungcancer cells. ONCOLOGY REPORTS. 2012 Sep;28(3):1117-25. doi:10.3892/or.2012.1901. (IF:1.835) [Q3]

73.  Xiao-jie Huang, Hai-ying Li, De-xi Chen, Xi-cheng Wang, Zai-cun Li, Ya-song Wu, TongZhang, Yan-qing Gao*, Hao Wu*. Clinical Analysis of Skin Lesions in 796 ChineseHIV-positive Patients. Acta Derm Venereol. 2011 Sep;91(5):552-6. doi:10.2340/00015555-1107. (IF:2.94) [Q2]

74.  HaiyingLi#, Xiaojie Huang# , Caiping Guo, Wen Wang, Zaicun Li, Tong Zhang, QiaoliPeng, Xinyue Chen, Hao Wu*. Heightened T-cell proliferation without anelevation of CD4+ T cell spontaneous apoptosis in AIDS patients. ClinicalImmunology. 2008 Dec;129(3):499-508. doi: 10.1016/j.clim.2008.08.004. (IF:3.93) [Q1]

1.    HIV/HCV共感染及HIV单独感染者临床特点及发病机制研究与应用，北京市科学技术委员会， 2019年度北京市科学技术奖科技进步奖二等奖（编号:2019-J06-2-03-R09）

2.    我国男男性接触（MSM）人群HIV-1新发感染及疾病进展模式研究，北京市科学技术委员会，首都十大疾病科技攻关创新型科技成果奖2013.

3.    艾滋病队列干预及致病机制研究，北京市科学技术委员会，首都十大疾病科技攻关创新型科技成果奖2012.

1. 刘志英，袁霖，粟斌，张彤，吴昊，刘利锋，陆小凡，张欣，王蕊，夏炜，黄晓婕. 可覆盖多亚型的HIV-1总DNA定量检测引物对、探针及检测试剂盒，2021年11月01日，中国，CN108998570B.

2. 徐俊杰，郑海涛，左忠林，黄晓婕，吕慧，段君义. 一种基于NBIOT与多传感器融合的智能药盒服药提醒系统，2025年10月11日，中国，CN202511449610.4.

（一）牵头/参与编写专家共识及专著14部：

1.  中国疾病预防控制中心性病艾滋病预防控制中心.《国家免费艾滋病抗病毒药物治疗手册（2023年版）》. 2023.6. ISBN 978-7-117-34843-0.

2.  徐俊杰,黄晓婕,刘昕超,等.中国HIV暴露前预防用药专家共识[J].中国艾滋病性病,2020,26(11):1265-1271. DOI:10.13419/j.cnki.aids.2020.11.34.

3.  张秋月, 张路坤, 何云, 等. 急性HIV感染诊疗管理专家共识（2025版） [J]. 中国艾滋病性病, 2025, 31(03): 226-35.

4.  张洋, 孙广强, 贾琳, 等. 中国成人HIV感染合并抑郁的诊疗与管理专家共识 [J]. 中国艾滋病性病, 2025, 31(02): 113-26.

5.  张彤, 石川, 等. 中国成人HIV感染合并焦虑诊疗与管理专家共识 [J]. 中国艾滋病性病, 2025, 31(01): 1-16.

6.  张路坤, 王辉,等. 中国HIV暴露前预防用药专家共识（2023版） [J]. 中国艾滋病性病,2023, 29(09): 954-61.

7.  中华医学会热带病与寄生虫学分会艾滋病学组. 人类免疫缺陷病毒/获得性免疫缺陷综合征患者血脂综合管理中国专家共识[J]. 中华内科杂志, 2023, 62(6): 83-94.

8.  中国性病艾滋病防治协会艾滋病药物预防与阻断专委会, 国家感染病临床研究中心南方科技大学附属第二医院. HIV急性感染期诊疗管理专家共识[J].中国艾滋病性病,2022,28(06):730-734.

9.  "十三五"国家科技重大专项艾滋病机会性感染课题组.艾滋病合并马尔尼菲篮状菌病临床诊疗的专家共识[J].西南大学学报(自然科学版),2020,42(07):61-75.

10. "十三五"国家科技重大专项艾滋病机会性感染课题组.艾滋病合并隐球菌病临床诊疗的专家共识[J].西南大学学报(自然科学版),2020,42(07):1-19.

11. "十三五"国家科技重大专项艾滋病机会性感染课题组.艾滋病合并肺孢子菌肺炎临床诊疗的专家共识[J].西南大学学报(自然科学版),2020,42(07):49-60.

12. "十三五"国家科技重大专项艾滋病机会性感染课题组.艾滋病合并弓形虫脑炎临床诊疗的专家共识[J].西南大学学报(自然科学版),2020,42(07):38-48.

13. "十三五"国家科技重大专项艾滋病机会性感染课题组.艾滋病合并巨细胞病毒病临床诊疗的专家共识[J].西南大学学报(自然科学版),2020,42(07):20-37.

14. 孙丽君,王爱玲,张福杰,等.HIV阳性孕产妇全程管理专家共识[J].中国艾滋病性病,2020,26(03):335-338.

（二）参与制定行业标准2项：

1.  马春涛, 金聪,李敬云, 耿文清, 马丽英, 任莉, 崔华露, 黄晓婕, 魏强, 蒋岩, 吴昊. T/CPMA 027-2023.《病原微生物菌（毒）种标准株 艾滋病病毒毒株建立技术规范》，北京，中华预防医学会，2023年.

2.  董薇, 徐杰, 赵燕, 管文辉, 阮连国, 黄晓婕, 何云, 沈银忠, 薛珲, 马伟, 马迎华, 杨杰, 朱彪. WS/T 2025. 《艾滋病病毒非职业暴露后预防服务标准》, 中华人民共和国卫生健康委员会, 2025年.